Company Filing History:
Years Active: 2025
Title: Umesh Gorakh Sagar: Innovator in Influenza Vaccine Development
Introduction
Umesh Gorakh Sagar is a notable inventor based in Pune, Maharashtra, India. He has made significant contributions to the field of vaccine development, particularly in the area of influenza vaccines. His innovative work has the potential to enhance public health by providing effective protection against influenza virus infections.
Latest Patents
Umesh Gorakh Sagar holds a patent for a "Stabilized live attenuated influenza vaccine compositions." This patent outlines compositions and methods for manufacturing a live attenuated influenza vaccine (LAIV) that can be delivered intranasally. The LAIV strains are based on cold-adapted, temperature-sensitive, and attenuated phenotypes of master donor viruses (MDVs). These strains contain the surface glycoprotein genes of wild-type pandemic or seasonal influenza strains. Notably, the vaccine manufacturing process avoids the use of eggs and is devoid of chromatography steps. The LAIV composition includes one or more live attenuated influenza vaccine viruses and is free from polymers and surfactants.
Career Highlights
Umesh Gorakh Sagar is currently associated with the Serum Institute of India Private Limited, a leading organization in vaccine production. His work at the institute has been pivotal in advancing vaccine technology and improving public health outcomes. His dedication to research and innovation has positioned him as a key figure in the field of immunology.
Collaborations
Umesh has collaborated with several professionals in his field, including Rajeev Mhalasakant Dhere and Leena Ravindra Yeolekar. These collaborations have fostered a productive environment for research and development, leading to significant advancements in vaccine technology.
Conclusion
Umesh Gorakh Sagar's contributions to the development of influenza vaccines exemplify the impact of innovation in public health. His work not only enhances vaccine efficacy but also paves the way for future advancements in immunization strategies.